BioSpace News Archive

Feb. 10, 2020 15:49 UTC Elorac to Present Naloxone Lotion Phase III Study Update at the 4 th World Congress of Cutaneous Lymphomas in Barcelona CHICAGO--( BUSINESS WIRE )-- Elorac, Inc., a biopharmaceutical company focused on developing best-in-class, innovative, proprietary drugs, announced that Scott Phillips, M.D., Sr. V.P. Scientific Affairs will present an update of its ongoing Phase III SPIRIT-2 trial evaluating the safety and efficacy of naloxone lotion for relief of pruritus

QT Ultrasound®, developers of the QTscan®, will be among the innovators in imaging technology to address audiences at some of the most influential industry events kicking off this new year.

Immunovia invites to a teleconference (in English) for investors, analysts and media on Friday, February 14th, 2020 at 8:30 am CET . Immunovia will publish the company’s Full Year 2019 report on February 14 th , 2020 at 8:00 am CET . Mats Grahn , CEO will present Immunovia and comment on the interim report for the period

Today, Health Leads announced the promotion of Carmita Padilla to the position of chief program and sites officer.

According to Healthy People 2020, America’s poorest children suffer high tooth decay rates, double that of non-poor children.

Government of Canada officials will hold a media availability to provide information on a novel coronavirus in Canada.

“I got tired of using products on the market that do not work very well and keep dying and losing memory,” said an inventor from Mitchell, Ind.

Houston hometown hero Mattress Mack of Gallery Furniture partnered with Mayo Clinic trained spine surgeon, Dr Steven Cyr from SASpine to discuss the multiple health benefits of the recently-released Tempur-Pedic Sleeptracker, an integrated smart-monitoring sleep response system.

Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced it has joined Behind the Seizure®, a cross-company collaboration established by BioMarin and Invitae that aims to provide faster diagnosis for young children with genetic diseases who experience seizures.

Feb. 10, 2020 13:00 UTC FISHERS, Ind.--( BUSINESS WIRE )-- Probo Medical (“Probo”), a leading provider of medical imaging equipment, parts, repair and service, announced today the acquisitions of Elite Medical Technologies, LLC (“Elite Medical”) and Future Medical Equipment, Ltd. (“Future Medical”). Terms of the transactions were not disclosed. “Probo is tremendously excited to announce these significant acquisitions,” said Michael Asmer, CEO of Probo Medical. “Over the past